In addition to their immunosuppressive capacity, glioma MDSCs have been associated with tumor angiogenesis because they express KDR (kinase insert domain receptor), also known as VEGFR2, which coordinates immune alterations with vascular defects, favoring the progression of the tumors [144]. This evidence concerns the gene KDR and central nervous system cancer.